BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27029507)

  • 1. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
    Gmitterová K; Heinemann U; Krasnianski A; Gawinecka J; Zerr I
    Eur J Neurol; 2016 Jun; 23(6):1126-33. PubMed ID: 27029507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of timing on CSF tests value for Creutzfeldt-Jakob disease diagnosis.
    Sanchez-Juan P; Sánchez-Valle R; Green A; Ladogana A; Cuadrado-Corrales N; Mitrová E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Krasnianski A; Equestre M; Slivarichová D; Saiz A; Calero M; Pocchiari M; Knight R; van Duijn CM; Zerr I
    J Neurol; 2007 Jul; 254(7):901-6. PubMed ID: 17385081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    J Neurol; 2016 Sep; 263(9):1847-61. PubMed ID: 27357003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review.
    Chohan G; Pennington C; Mackenzie JM; Andrews M; Everington D; Will RG; Knight RS; Green AJ
    J Neurol Neurosurg Psychiatry; 2010 Nov; 81(11):1243-8. PubMed ID: 20855493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.
    Bahl JM; Heegaard NH; Falkenhorst G; Laursen H; Høgenhaven H; Mølbak K; Jespersgaard C; Hougs L; Waldemar G; Johannsen P; Christiansen M
    Neurobiol Aging; 2009 Nov; 30(11):1834-41. PubMed ID: 18339451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.
    Koscova S; Zakova Slivarichova D; Tomeckova I; Melicherova K; Stelzer M; Janakova A; Kosorinova D; Belay G; Mitrova E
    Mol Neurobiol; 2017 Oct; 54(8):5919-5927. PubMed ID: 27665282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid tau levels are a marker for molecular subtype in sporadic Creutzfeldt-Jakob disease.
    Karch A; Hermann P; Ponto C; Schmitz M; Arora A; Zafar S; Llorens F; Müller-Heine A; Zerr I
    Neurobiol Aging; 2015 May; 36(5):1964-8. PubMed ID: 25749129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
    Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human cerebrospinal fluid malate dehydrogenase 1 in sporadic Creutzfeldt-Jakob disease patients.
    Schmitz M; Llorens F; Pracht A; Thom T; Correia Â; Zafar S; Ferrer I; Zerr I
    Aging (Albany NY); 2016 Nov; 8(11):2927-2935. PubMed ID: 27852982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study.
    Coulthart MB; Jansen GH; Olsen E; Godal DL; Connolly T; Choi BC; Wang Z; Cashman NR
    BMC Neurol; 2011 Oct; 11():133. PubMed ID: 22032272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid markers in sporadic Creutzfeldt-Jakob disease.
    Zanusso G; Fiorini M; Ferrari S; Gajofatto A; Cagnin A; Galassi A; Richelli S; Monaco S
    Int J Mol Sci; 2011; 12(9):6281-92. PubMed ID: 22016658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylated tau in cerebrospinal fluid as a marker for Creutzfeldt-Jakob disease.
    Van Everbroeck B; Green AJ; Vanmechelen E; Vanderstichele H; Pals P; Sanchez-Valle R; Corrales NC; Martin JJ; Cras P
    J Neurol Neurosurg Psychiatry; 2002 Jul; 73(1):79-81. PubMed ID: 12082054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies.
    Ladogana A; Sanchez-Juan P; Mitrová E; Green A; Cuadrado-Corrales N; Sánchez-Valle R; Koscova S; Aguzzi A; Sklaviadis T; Kulczycki J; Gawinecka J; Saiz A; Calero M; van Duijn CM; Pocchiari M; Knight R; Zerr I
    J Neurol; 2009 Oct; 256(10):1620-8. PubMed ID: 19444528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.
    Pennington C; Chohan G; Mackenzie J; Andrews M; Will R; Knight R; Green A
    Neurosci Lett; 2009 May; 455(1):56-9. PubMed ID: 19429106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease.
    Llorens F; Zafar S; Ansoleaga B; Shafiq M; Blanco R; Carmona M; Grau-Rivera O; Nos C; Gelpí E; Del Río JA; Zerr I; Ferrer I
    Neuropathol Appl Neurobiol; 2015 Aug; 41(5):631-45. PubMed ID: 25134744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PrP mRNA and protein expression in brain and PrP(c) in CSF in Creutzfeldt-Jakob disease MM1 and VV2.
    Llorens F; Ansoleaga B; Garcia-Esparcia P; Zafar S; Grau-Rivera O; López-González I; Blanco R; Carmona M; Yagüe J; Nos C; Del Río JA; Gelpí E; Zerr I; Ferrer I
    Prion; 2013; 7(5):383-93. PubMed ID: 24047819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal Fluid Biomarker-Based Diagnosis of Sporadic Creutzfeldt-Jakob Disease: A Validation Study for Previously Established Cutoffs.
    Llorens F; Karch A; Golanska E; Schmitz M; Lange P; Sikorska B; Liberski PP; Zerr I
    Dement Geriatr Cogn Disord; 2017; 43(1-2):71-80. PubMed ID: 28056460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total and Phosphorylated Cerebrospinal Fluid Tau in the Differential Diagnosis of Sporadic Creutzfeldt-Jakob Disease and Rapidly Progressive Alzheimer's Disease.
    Hermann P; Haller P; Goebel S; Bunck T; Schmidt C; Wiltfang J; Zerr I
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.